Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Prevention of infectious complications in pediatric HSCT

Bone Marrow Transplantation volume 42, pages S77–S81 (2008)Cite this article

Abstract

Infectious complications constitute a major cause of morbidity and mortality in pediatric and adult patients undergoing hematopoietic SCT (HSCT). Current guidelines and recommendations for prevention of infections in children after HSCT are presented in this mini review. The paper is based on evidence-based recommendations rated by the strength of the recommendation and the quality of the supporting evidence. Prophylaxis strategy based on risk stratification includes: (1) general infection control in hospital environment, (2) pharmacological approach related to antibacterial, antifungal and antiviral agents and (3) vaccination. Although most studies were carried out on adults only, some included both pediatric and adult patients. No differences in prophylaxis strategy and efficacy among age groups are reported. With changing practices, transplant teams are encouraged to review local patterns of prophylaxis strategy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention; Infectious Disease Society of America; American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49: 1–125.

  2. O'Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ . Infections in patients with hematological cancer: recent developments. Hematology Am Soc Hematol Educ Program 2003; 438–472.

  3. Brown JMY . Fungal infections after hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Cell Transplantation. Blackwell Publishing: Malden, 2004, pp 683–700.

    Google Scholar 

  4. Strasfeld L, Weinstock DM . Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents. Expert Rev Anti Infect Ther 2006; 4: 457–468.

    Article  CAS  Google Scholar 

  5. Nucci M, Andrade F, Vigorito A, Trabasso P, Aranha JF, Maiolino A et al. Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation. Transpl Infect Dis 2003; 5: 167–173.

    Article  CAS  Google Scholar 

  6. Dykewicz CA . Hospital infection control in hematopoietic stem cell transplant recipients. Emerg Infect Dis 2001; 7: 263–267.

    Article  CAS  Google Scholar 

  7. Dykewicz CA . Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections. Biol Blood Marrow Transplant 2001; 7 (Supp l): 19S–22S.

    Article  Google Scholar 

  8. Dykewicz CA . Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001; 33: 139–144.

    Article  CAS  Google Scholar 

  9. van de Wetering MD, de Witte MA, Kremer LC, Offringa M, Scholten RJ, Caron HN . Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials. Eur J Cancer 2005; 41: 1372–1382.

    Article  CAS  Google Scholar 

  10. Bucaneve G, Castagnola E, Viscoli C, Leibovici L, Menichetti F . Quinolone prophylaxis for bacterial infections in afebrile high-risk neutropenic patients. EJC Supplements 2007; 2: 5–12.

    Article  Google Scholar 

  11. Maltezou HC, Petropoulos D, Choroszy M, Gardner M, Mantzouranis EC, Rolston KV et al. Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation. Bone Marrow Transplant 1997; 20: 879–881.

    Article  CAS  Google Scholar 

  12. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845–851.

    Article  CAS  Google Scholar 

  13. Marr KA, Seidel K, Slavin MA, Bowden RA, Schoch HG, Flowers ME et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000; 96: 2055–2061.

    CAS  PubMed  Google Scholar 

  14. Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Gersten ID et al. Results of a randomized, double-blind trial of fluconazole (FLU) vs. voriconazole (VORI) for the prevention of invasive fungal infections (IFI) in 600 allogeneic blood and marrow transplant (BMT) patients. Blood 2007; 110: 163 (abstract).

    Google Scholar 

  15. Ljungman P, Reusser P, de la Camara R, Einsele H, Engelhard D, Ribaud P et al. Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant 2004; 33: 1075–1081.

    Article  CAS  Google Scholar 

  16. Slavin MA, Meyers JD, Remington JS, Hackman RC . Toxoplasma gondii infection in marrow transplant recipients: a 20-year experience. Bone Marrow Transplant 1994; 13: 549–557.

    CAS  PubMed  Google Scholar 

  17. Grady R . Safety profile of quinolone antibiotics in the pediatric population. Pediatr Infect Dis J 2003; 22: 1128–1132.

    Article  Google Scholar 

  18. Castagnola E, Boni L, Giacchino M, Cesaro S, De Sio L, Garaventa A et al. A multicenter, randomized, double blind placebo-controlled trial of amoxicillin–clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer. Pediatr Infect Dis J 2003; 22: 359–365.

    PubMed  Google Scholar 

  19. Castagnola E, Bagnasco F, Faraci M, Caviglia I, Caruso S, Cappelli B et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant 2008; 41: 339–347.

    Article  CAS  Google Scholar 

  20. Prentice HG, Kibbler CC, Prentice AG . Towards a targeted, risk-based, antifungal strategy in neutropenic patients. Br J Haematol 2000; 110: 273–284.

    Article  CAS  Google Scholar 

  21. Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335–347.

    Article  CAS  Google Scholar 

  22. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545–1552.

    Article  CAS  Google Scholar 

  23. Castagnola E, Cappelli B, Erba D, Rabagliati A, Lanino E, Dini G . Cytomegalovirus infection after bone marrow transplantation in children. Hum Immunol 2004; 65: 416–422.

    Article  Google Scholar 

  24. Winston DJ, Baden LR, Gabriel DA, Emmanouilides C, Shaw LM, Lange WR et al. Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract. Biol Blood Marrow Transplant 2006; 12: 635–640.

    Article  CAS  Google Scholar 

  25. Einsele H, Reusser P, Bornhauser M, Kalhs P, Ehninger G, Hebart H et al. Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Blood 2006; 107: 3002–3008.

    Article  CAS  Google Scholar 

  26. Erard V, Guthrie KA, Varley C, Heugel J, Wald A, Flowers ME et al. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007; 110: 3071–3077.

    Article  CAS  Google Scholar 

  27. Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737–746.

    Article  CAS  Google Scholar 

  28. Machado CM . Reimmunization after bone marrow transplantation---current recommendations and perspectives. Braz J Med Biol Res 2004; 37: 151–158.

    Article  CAS  Google Scholar 

  29. Meisel R, Kuypers L, Dirksen U, Schubert R, Gruhn B, Strauss G et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 2322–2326.

    Article  CAS  Google Scholar 

  30. Cordonnier C, Labopin M, Chesnel V, Ribaud P, De la Camara R, Martino R et al. Inluence of immunisation timing on the response to conjugate-pneumococcal vaccine after allogeneic stem cell transplant: final results of the EBMT IDWP01 Trial. Bone Marrow Transplant 2008; 41 (Suppl 1): S2 (abstract O102).

    Google Scholar 

  31. Ilan Y, Nagler A, Adler R, Tur-Kaspa R, Slavin S, Shouval D . Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology 1993; 104: 1818–1821.

    Article  CAS  Google Scholar 

  32. Wimperis JZ, Brenner MK, Prentice HG, Reittie JE, Karayiannis P, Griffiths PD et al. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet 1986; 1: 339–343.

    Article  CAS  Google Scholar 

  33. Molrine DC . Recommendations for immunizations in stem cell transplantation. Pediatr Transplant 2003; 7 (Suppl 3): 76–85.

    Article  Google Scholar 

  34. Molrine DC, Guinan EC, Antin JH, Parsons SK, Weinstein HJ, Wheeler C et al. Donor immunization with Haemophilus influenzae type B (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012–3018.

    CAS  PubMed  Google Scholar 

  35. Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831–836.

    Article  CAS  Google Scholar 

  36. Storek J, Dawson MA, Lim LC, Burman BE, Stevens-Ayers T, Viganego F et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 2004; 33: 337–346.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. J Styczynski and L Gil: These authors contributed equally to this study.

Authors and Affiliations

  1. Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland

    J Styczynski

  2. Department of Hematology, University of Medical Sciences, Poznan, Poland

    L Gil

Authors
  1. J Styczynski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Gil
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the EBMT Paediatric Diseases Working Party

Corresponding author

Correspondence to J Styczynski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Styczynski, J., Gil, L. & on behalf of the EBMT Paediatric Diseases Working Party. Prevention of infectious complications in pediatric HSCT. Bone Marrow Transplant 42 (Suppl 2), S77–S81 (2008). https://doi.org/10.1038/bmt.2008.289

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.289

Keywords

This article is cited by

Search

Advanced search

Quick links